Clinical Research Directory
Browse clinical research sites, groups, and studies.
Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons
Sponsor: Technische Universität Dresden
Summary
ProtoChoice-P is a prospective multicenter trial to evaluate proton therapy in patients suffering from prostate cancer. Primary aim of the study is a decrease of moderate or severe genito-urinary or intestinal side effects (Common Terminology Criteria for Adverse Events (CTCAE) 4.0 grade 2 or higher) by the use of proton therapy. Secondary endpoints contain assessment of quality of life, biochemical recurrence and recurrence free survival as well as overall survival and economic comparison between photon and proton therapy.
Official title: Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons in Standard Fractionation and Standard Dosage
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2016-09
Completion Date
2026-08-23
Last Updated
2026-09-01
Healthy Volunteers
No
Conditions
Interventions
Radiotherapy with protons
Radiotherapy with photons
Locations (3)
University Hospital Carl Gustav Carus, Department of Radiotherapy and Radiation Oncology
Dresden, Germany
Klinikum rechts der Isar, Technische Universität München
Munich, Germany
Universitätsklinik für Radioonkologie, Universitätsklinikum Tübingen
Tübingen, Germany